我国药物经济学应用热点探讨  

Hot Spot of Pharmacoeconomics Research and Application in China

作　　者：杨廉平[1] 张新平[1] 

机构地区：[1]华中科技大学同济医学院医药卫生管理学院,武汉430030

出　　处：《中国药房》2012年第38期3553-3555,共3页China Pharmacy

摘　　要：目的:促进我国药物经济学应用发展。方法:采用文献分析法,梳理和探讨我国药物经济学应用的热点领域。结果与结论:当前我国药物经济学应用热点领域包括:以价值为基础的药品定价,促进药品创新,保障有效药物的可及性和效果;开展预算影响分析,从预算持有者的角度出发,关注药品服务变化、预算影响及经济可承担性;从决策者角度发挥药物经济学作用。药物经济学基于研究成果数量及其整合能力,能够在宏观、中观、微观多层次政策决策时提供循证支持。OBJECTIVE： To promote the development of pharmacoeconomics application in China. METHODS： Using litera- ture analysis, hot spots of pharmacoeconomics research and application were summarized and explored in China. RESULT＆CON- CLUSIONS： Hot spot of pharmacoeconomics research and application included： value-based drug pricing can promote drug innova- tion and protect the availability and efficacy of effective drugs; budget impact analysis, which is from the view of budget holders. focuses on changes in pharmaceutical services, budget impact and the economy affordability; use pharmacoeconomics from the view of policy makers. Pharmacoeconomics is able to integrate evidence-based supports as the multi-level policy decisions based on the number of research results and ability.

关 键 词：药物经济学 药品定价 预算影响分析 政府决策 

分 类 号：R956[医药卫生—药学]